文献速递临床试验与 GCP

研究方案更新:Face Your Fears——基于虚拟现实认知行为治疗(VR-CBT)与标准认知行为治疗用于精神分裂症谱系障碍患者偏执观念的比较:一项随机临床试验

Update to the study protocol Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.
PubMed 文献 · Trials · 2023-01-23

本文是对已发表研究方案的更新,因丹麦首都大区健康研究伦理委员会以试验已启动为由拒绝了更改主要结局的批准,故保留迫害观念量表(GPTS)B部分为主要结局、社会参照观念A部分为次要结局。两组干预与评估不变,样本量计算不变,未接触初步数据,已在ClinicalTrials.gov透明记录变更。

要点

  • 伦理委员会拒绝更改主要结局,故主要结局仍为GPTS B部分迫害观念。
  • GPTS A部分社会参照观念仍为次要结局,与已发表方案相反。
  • 两组干预与评估未变,样本量计算不变,未接触初步数据。

核心结论

  • 因伦理委员会以试验已启动为由拒绝更改主要结局,保留GPTS B部分迫害观念为主要结局、A部分社会参照观念为次要结局。
  • 结局交换未影响试验参与或知情同意,两组干预与评估未变,样本量计算不变。

研究设计与样本

  • 本文为已发表随机临床试验方案的更新说明,试验注册号NCT04902066,首次发布2021年4月19日。

主要发现

  • 丹麦首都大区健康研究伦理委员会近期以试验已启动为由拒绝了更改主要结局的批准。
  • 两个结局共同构成GPTS及所试图治疗的统一概念即偏执观念。
  • 因是盲法且方法学严谨的试验,未接触且仍无法接触初步数据,不知两组干预分布及潜在效应。

关键数值与推荐

  • 主要结局为GPTS B部分迫害观念,次要结局为GPTS A部分社会参照观念。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We unfortunately need to make an update to our published study protocol that describes a significant change in the design of the study. The Committee on Health Research Ethics of the Capital Region Denmark recently rejected the approval of changing the primary outcome in the trial, on the invariable grounds that the trial has already commenced. It is therefore necessary to retain the Green Paranoid Thought Scale (GPTS) part B, ideas of persecution, as our primary outcome, and GPTS part A, ideas of social reference, as a secondary outcome, which is described opposite in our published study protocol. The exchange of outcomes has not affected participation in our trial or the informed consent. Intervention in both groups and assessments are unchanged. The two outcomes together constitute GPTS and the unifying concept we attempt to treat, namely paranoid ideations. As this is a blinded, methodologically rigorous trial, we did not have-and still do not have-access to preliminary data, and therefore, we have no knowledge of the distribution of our two intervention groups nor the potential effect of the intervention. The power calculation remains unchanged irrespective of the selection of the primary outcome. We have been fully transparent with the changes in primary and secondary outcomes on ClinicalTrials.gov throughout the trial. Due to the considerations mentioned above, we assumed that there would not be any ethical implications of the change of primary outcome. We sincerely apologize for the irregularity caused because of this assumption.Trial registrationClinicalTrials.gov NCT04902066 . Initial release April 19th, 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jeppesen UN, Due AS, Mariegaard L, et al. Update to the study protocol Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial. Trials. 2023. PMID: 36691039. doi:10.1186/s13063-023-07069-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。